143 related articles for article (PubMed ID: 16496667)
1. Deposition of insulin powders for inhalation in vitro and pharmacodynamic evaluation of absorption promoters in rats.
Yang DB; Zhu JB; Zhu H; Zhang XS
Yao Xue Xue Bao; 2005 Dec; 40(12):1069-74. PubMed ID: 16496667
[TBL] [Abstract][Full Text] [Related]
2. The preparation and application of pulmonary surfactant nanoparticles as absorption enhancers in insulin dry powder delivery.
Zhang Y; Zhu J; Tang Y; Chen X; Yang Y
Drug Dev Ind Pharm; 2009 Sep; 35(9):1059-65. PubMed ID: 19640250
[TBL] [Abstract][Full Text] [Related]
3. Hypoglycemic efficacy of pulmonary delivered insulin dry powder aerosol in rats.
Chen XJ; Zhu JB; Wang GJ; Zhou MX; Xin FM; Zhang N; Wang CX; Xu YN
Acta Pharmacol Sin; 2002 May; 23(5):467-70. PubMed ID: 11978199
[TBL] [Abstract][Full Text] [Related]
4. Physical characteristics and aerosolization performance of insulin dry powders for inhalation prepared by a spray drying method.
You Y; Zhao M; Liu G; Tang X
J Pharm Pharmacol; 2007 Jul; 59(7):927-34. PubMed ID: 17637186
[TBL] [Abstract][Full Text] [Related]
5. Inhaled micronized crystalline human insulin using a dry powder inhaler: dose-response and time-action profiles.
Rave K; Nosek L; Heinemann L; Gonzales C; Ernest CS; Chien J; Muchmore D
Diabet Med; 2004 Jul; 21(7):763-8. PubMed ID: 15209771
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and pharmacodynamics of controlled release insulin loaded PLGA microcapsules using dry powder inhaler in diabetic rats.
Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Hassanzadeh K; Mahdavi H; Koohsoltani M; Nokhodchi A
Biopharm Drug Dispos; 2010 Mar; 31(2-3):189-201. PubMed ID: 20238376
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of inhaled recombinant human insulin dry powders: pharmacokinetics, pharmacodynamics and 14-day inhalation.
He J; Zhang G; Zhang Q; Chen J; Zhang Y; An X; Wang P; Xie S; Fang F; Zheng J; Tang Y; Zhu J; Yu Y; Chen X; Lu Y
J Pharm Pharmacol; 2019 Feb; 71(2):176-184. PubMed ID: 30324757
[TBL] [Abstract][Full Text] [Related]
8. Insulin-micro- and nanoparticles for pulmonary delivery.
Klingler C; Müller BW; Steckel H
Int J Pharm; 2009 Jul; 377(1-2):173-9. PubMed ID: 19446621
[TBL] [Abstract][Full Text] [Related]
9. Insulin-loaded PLGA/cyclodextrin large porous particles with improved aerosolization properties: in vivo deposition and hypoglycaemic activity after delivery to rat lungs.
Ungaro F; d'Emmanuele di Villa Bianca R; Giovino C; Miro A; Sorrentino R; Quaglia F; La Rotonda MI
J Control Release; 2009 Apr; 135(1):25-34. PubMed ID: 19154761
[TBL] [Abstract][Full Text] [Related]
10. Effect of additives on insulin absorption from intratracheally administered dry powders in rats.
Todo H; Okamoto H; Iida K; Danjo K
Int J Pharm; 2001 Jun; 220(1-2):101-10. PubMed ID: 11376972
[TBL] [Abstract][Full Text] [Related]
11. Nasal absorption enhancement of insulin by sodium deoxycholate in combination with cyclodextrins.
Zhang Y; Jiang XG; Yao J
Acta Pharmacol Sin; 2001 Nov; 22(11):1051-6. PubMed ID: 11749800
[TBL] [Abstract][Full Text] [Related]
12. State of insulin self-association does not affect its absorption from the pulmonary route.
Hussain A; Ahsan F
Eur J Pharm Sci; 2005 Jun; 25(2-3):289-98. PubMed ID: 15911225
[TBL] [Abstract][Full Text] [Related]
13. Inhaled insulin--does it become reality?
Siekmeier R; Scheuch G
J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():81-113. PubMed ID: 19218634
[TBL] [Abstract][Full Text] [Related]
14. Solid lipid nanoparticles for pulmonary delivery of insulin.
Liu J; Gong T; Fu H; Wang C; Wang X; Chen Q; Zhang Q; He Q; Zhang Z
Int J Pharm; 2008 May; 356(1-2):333-44. PubMed ID: 18281169
[TBL] [Abstract][Full Text] [Related]
15. Aminated gelatin microspheres as a nasal delivery system for peptide drugs: evaluation of in vitro release and in vivo insulin absorption in rats.
Wang J; Tabata Y; Morimoto K
J Control Release; 2006 Jun; 113(1):31-7. PubMed ID: 16707188
[TBL] [Abstract][Full Text] [Related]
16. Formulation and in vitro evaluation of highly dispersive insulin dry powder formulations for lung administration.
Depreter F; Amighi K
Eur J Pharm Biopharm; 2010 Nov; 76(3):454-63. PubMed ID: 20797437
[TBL] [Abstract][Full Text] [Related]
17. Alteration of the pancreatic endocrine component in the early stage of acute necrotic pancreatitis in rats.
Li YY; Zhu GY; Gao YX; Yang ZY; Wang ZY
Chin J Dig Dis; 2006; 7(3):164-9. PubMed ID: 16808797
[TBL] [Abstract][Full Text] [Related]
18. Artificial pulmonary surfactant as a carrier for intratracheally instilled insulin.
Ji Y; Liu C; Pei YY
Acta Pharmacol Sin; 2007 May; 28(5):744-50. PubMed ID: 17439732
[TBL] [Abstract][Full Text] [Related]
19. High azithromycin loading powders for inhalation and their in vivo evaluation in rats.
Zhang Y; Wang X; Lin X; Liu X; Tian B; Tang X
Int J Pharm; 2010 Aug; 395(1-2):205-14. PubMed ID: 20595022
[TBL] [Abstract][Full Text] [Related]
20. [Pulmonary delivery of insulin lipid suspension].
Jiang ZQ; Lu J
Yao Xue Xue Bao; 2002 May; 37(5):378-82. PubMed ID: 12579846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
